Stemina’s Human Stem Cell-Based Test Demonstrates Potential to Predict Which Drugs and Chemicals Cause Birth Defects
-- EPA’s ToxCast™ evaluation of the developmental toxicity risk of 1,065 compounds using Stemina’s devTOX quickPredict test (devTOXqP) published in Toxicological Sciences -- devTOXqP is the only human test for assessing a drug or chemical’s potential to cause...
Leading Lung Cancer Expert Joins HealthMyne Clinical Advisory Board
Dr. Carey Thomson brings broad expertise in lung cancer screening advocacy, best practices and education to increase the detection of early stage lung cancer
Madison company’s surgery imaging device approved by FDA
OnLume's image-guided surgery device using fluorescence has been approved by the U.S. Food and Drug Administration.ONLUME A device developed by a Madison company to help surgeons better see tissue during operations has been approved by the U.S. Food and Drug...
Australian winner of Zurich’s global Innovation Championship announced
Zurich Australia Insurance has announced the Australian winner of its global Innovation Championship. Now in its second year, the innovation contest offers start-ups the opportunity to work with the global insurer to develop a pilot program that will make their...
Phoenix Awarded US Army IDIQ Contract to Demonstrate Neutron Radiography Techniques for Munitions Inspection
FITCHBURG, Wis., Jan. 30, 2020 /PRNewswire/ -- Madison-based nuclear technology company Phoenix, LLC. has been awarded a $10 million ceiling IDIQ (indefinite quantity, indefinite delivery) contract with the US Army to demonstrate improved neutron radiography and X-ray...
SHINE & IOCB deliver Lu-177 doses to GE
SHINE and IOCB Prague deliver patient dose quantities of lutetium-177 to GE Healthcare, advance therapeutic isotope toward commercialization
Rose Higgins Named CEO of HealthMyne
Higgins brings an extensive background in executive management and leadership to the quickly expanding company
Early changes in cell‐free DNA levels in newly transplanted heart transplant patients
Abstract Heart transplantation is a well‐established therapy for end‐stage heart failure in children and young adults. The highest risk of graft loss occurs in the first 60 days post‐transplant. Donor fraction of cell‐free DNA is a highly sensitive marker of graft...
The 2020 30 under 30 Consumer Technology
Fetch Rewards Cofounders, Fetch Rewards Wes Schroll wondered why grocery loyalty programs rewarded people for being loyal to a store and not the brands they were buying. Today, over two million people use Fetch's app to scan their receipts and receive points from...
Pops on the go virtual care system empowers those with diabetes to Own Their Life®
Over 400 million individuals worldwide, according to the World Health Organization (WHO), have diabetes, living each day on the precipice of health determined by the level of sugar in their bloodstream. The vigilance required to ensure that their levels are neither too high nor too low can often become all-encompassing. A circumstance that Lonny Stormo, co-founder and CEO of the Oak Park Heights, Minnesota-based startup, Pops, truly understands.